Brigette Roberts insider trades
Open-market stock purchases and sales by Brigette Roberts, Chief Corp. Affairs Officer at Quince Therapeutics, Inc, from SEC Form 4 filings since May 18, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $3.1K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $20.6K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $11.2K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $6.2K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $32.6K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $12K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $186K |
| May 18, 2026 | QNCX Quince Therapeutics, Inc | Bought (not open market) | $5.7M |
Companies traded
- QNCX Quince Therapeutics, Inc: other filings, last May 18, 2026